11-100859615-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BP4
The NM_152432.4(ARHGAP42):c.374G>A(p.Gly125Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,498,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152432.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGAP42 | NM_152432.4 | c.374G>A | p.Gly125Asp | missense_variant | 4/24 | ENST00000298815.13 | NP_689645.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGAP42 | ENST00000298815.13 | c.374G>A | p.Gly125Asp | missense_variant | 4/24 | 5 | NM_152432.4 | ENSP00000298815.7 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000259 AC: 3AN: 115616Hom.: 0 AF XY: 0.0000162 AC XY: 1AN XY: 61844
GnomAD4 exome AF: 0.00000594 AC: 8AN: 1346716Hom.: 0 Cov.: 28 AF XY: 0.00000604 AC XY: 4AN XY: 662108
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.374G>A (p.G125D) alteration is located in exon 4 (coding exon 4) of the ARHGAP42 gene. This alteration results from a G to A substitution at nucleotide position 374, causing the glycine (G) at amino acid position 125 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at